BAY SHORE TRUST enters TELOMIR PHARMACEUTICALS, INC. with 8.61M shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Indirect Derivatives
Filed: 2/8/2024ACC: 0000897069-24-000287
10% Owner
Since Feb 2024
8.61M
Baseline shares
0% direct
24.39K
Direct ownership
1 position
2.44M
Derivative underlying
1 instrument
4
Security positions
8.59M indirect
Non-Derivative Holdings4
Common Stock
IndirectShares owned1.85M
Common Stock
DirectShares owned24.39K
Common Stock
IndirectShares owned5.41M
Common Stock
IndirectShares owned1.33M
Total
24.39K direct·8.59M indirect8.61M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.85M | Indirect |
| Common Stock | 24.39K | Direct |
| Common Stock | 5.41M | Indirect |
| Common Stock | 1.33M | Indirect |
| Total | 8.61M | 24.39K direct·8.59M indirect |
Derivative Holdings1
Common Stock (right to buy)
IndirectUnderlying security
Common Stock
Underlying shares
2.44M
Shares owned
N/A
Exercise price
3.73
Expiration
—
Exercise window
—
Total
Underlying
2.44M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Common Stock (right to buy) Indirect | Common Stock | 3.73 | — | — | 2.44M | N/A |
| Total | 2.44M | 0.00 | ||||